📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
HOME › COVERAGE › ARQT › EARNINGS
EARNINGS HUB
News Coverage Earnings Hub Earnings Report Grades
$ARQT
ARQT Earnings: Beat 3/4 · 4 quarters tracked
LAST 30 DAYS
3 articles
AVG GRADE
NEUTRAL
score: 0.17
SENTIMENT
—
TOTAL VIEWS
18
◈ EARNINGS HUB · 2026-06

ARQT Earnings: Beat, Surprise History & Forecast

3/4 quarters beaten · Last EPS $0.11 (+150.6%) · AI Grade: NEUTRAL
◈ ESEN AI · EARNINGS PREVIEW
ARQT reported EPS of $0.11 in its most recent quarter (2026-06), beating consensus estimate of $0.04 by +150.6%. Over the last 4 quarters, the company has beaten estimates 3 times (75% beat rate) with an average surprise of +78.6%. ESEN AI grade: NEUTRAL.
LAST EPS
$0.11
est $0.04
LAST SURPRISE
+150.6%
2026-06
BEAT RATE
3/4
beats / quarters
AVG SURPRISE
+78.6%
last 4Q
◆ EPS MOMENTUM
PERIOD
ACTUAL EPS
ESTIMATE
SURPRISE
2026-06-30
$0.11
$0.04
+150.6%
2026-03-31
$-0.09
$-0.08
-7.4%
2025-12-31
$0.13
$0.12
+12.4%
2025-09-30
$0.06
$-0.10
+158.9%
◈ RELATED EARNINGS NEWS
seekingalpha
2026-08-06
Arcutis Biotherapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ARQT) 2026-08-06
LOW
finance.yaho
2026-08-06
Arcutis President and CEO Todd Watanabe Sells 4,375 Shares for $114,275 as Q2 Results Demonstrate Profitability
LOW
manilatimes.
2026-07-15
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
NEUTRAL
manilatimes.
2026-07-08
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
NEUTRAL
manilatimes.
2026-06-29
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
HIGH
 View all ARQT news →
◈ FREQUENTLY ASKED QUESTIONS
When did $ARQT last report earnings?
ARQT last reported earnings on 2026-06-30, with actual EPS of $0.11 vs estimate of $0.04.
Did $ARQT beat earnings estimates?
Yes, ARQT beat consensus EPS by +150.6% in its most recent quarter.
What is $ARQT's earnings beat rate?
ARQT has beaten consensus EPS in 3 of 4 quarters (75%). Average surprise: +78.6%.
NEWS-BASED SECTOR EXPOSURE ANALYSISPOWERED BY CLAUDE HAIKU 4.5NOT INVESTMENT ADVICE
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours. Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice